Gapping down
In reaction to disappointing earnings/guidance:
- IVAC -17.6%, CGNX -16.2%, TPR -7.2%, AXGN -7%, I -6.7%, RCII -6%, SHOP -6%, SMG -5%, FLWS -3.5%, RIG -3%, INCY -2.8%, INST -2.6%, SBAC -1.7%, IIVI -1.6%, PFE -1.4%, RDC -1.2%, AMRC -0.8%
Other news:
- KLXI -8% (sells ASG business to Boeing (BA); to spin-off its ESG Business to KLX shareholders)
- XPER -3.6% (light volume -- ahead of earnings on Thursday)
- WSR -2% (9.6% shareholder KBS files proxy materials with letter to shareholders)
- FR -1.8% (commenced underwritten public offering of 4.8 million shares of common stock)
- ABTX 0% (Allegiance Bancshares to merge with Post Oak Bancshares)
Analyst comments:
- CRON -3.5% (downgraded to Sell from Hold at Canaccord Genuity)
- BTI -2% (downgraded to Neutral from Overweight at Piper Jaffray)
![]()
Gapping up
In reaction to strong earnings/guidance:
- INGN +24%, NTRI +12.1%, ELVT +9.9%, EFII +9.4%, QTNA +8.1%, THC +5.7%, HLIT +5.5%, ALSN +4.6%, MTZ +4.5%, IDTI +4%, FDP +3.8%, AKAM +3.6%, UAA +3.6%, APTI +3.4%, ADM +3.1%, TNET +2.6%, KAI +2.4%, WCG +2.4%, HEP +2.4%, AEIS +2%, NBIX +1.8%, EDGE +1.8%, MX +1.6%, WLL +1.5%, ETN +1.3%, MRK +1.1%, VRNS +1%, EMR +0.9%, JCI +0.9%, AET +0.5%
Other news:
- KPTI +26.1% (Karyopharm Therapeutics reports 'positive' top-line results from the Phase 2b STORM study evaluating the Company's lead, oral Selective Inhibitor of Nuclear Export (SINE) compound selinexor in heavily pretreated patients with refractory multiple myeloma)
- HCA +4% (ticking higher following THC results)
- KL +1% (identifies potential new source of gold production in Northern Australia)
Analyst comments:
- ROKU +1.4% (initiated with a Overweight at KeyBanc Capital Mkts)
- CTXS +1.2% (added to Conviction Buy List at Goldman)
Early premarket gappersGapping up:
- INGN +25.2%, KPTI +24.8%, EFII +14.7%, NTRI +12.1%, ELVT +9.9%, QTNA +8.1%, THC +5.7%, ALSN +4.6%, MTZ +4.5%, AKAM +4.1%, HCA +4%, IDTI +4%, FDP +3.8%, APTI +3.4%, TNET +2.6%, WCG +2.4%, AEIS +2%, NBIX +1.8%, MX +1.6%, HLIT +1.4%, WLL +1.2%, VRNS +1%
Gapping down:
- IVAC -16%, CGNX -15.7%, AXGN -7%, RCII -6%, XPER -3.6%, RIG -3%, INST -2.6%, WSR -2%, SBAC -1.7%, AMRC -0.8%, TXRH -0.5%, COMM -0.5%
After Hours Summary: INGN +24.5%, NTRI +12% higher, while CGNX -16%, AXGN -7%, RIG -3% lower following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: INGN +24.5%, EFII +14.8%, NTRI +11.9%, QTNA +8.1%, THC +5.7%, MX +4.8%, ALSN +4.6%, IDTI +4.4%, MTZ +4%, ELVT +3.5%, AKAM +2.8%, VRNS +1.8%
Companies trading higher in after hours in reaction to news: KPTI +27.3% (reports 'positive' top-line results from the Phase 2b STORM study evaluating the Company's lead, oral Selective Inhibitor of Nuclear Export compound selinexor in heavily pretreated patients with refractory multiple myeloma), HCA +4% (ticking higher following THC results)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CGNX -15.7%, IVAC -15.3%, AXGN -7%, RIG -3%
Companies trading lower in after hours in reaction to news: XPER -3.6% (light volume -- ahead of earnings on Thursday), WSR -2% (9.6% shareholder KBS files proxy materials with letter to shareholders), FR -1.8% (commenced underwritten public offering of 4.8 million shares of common stock)
![]()